Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Fomsgaard

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Clinical and Vaccine Immunology : CVI|June 8, 2012
Assessment of HIV-1 patient recruitability in the Republic of Guinea-Bissau using African versus North American hematology and biochemistry reference intervalsVictor Raúl Gómez Román, Sanne Skov Jensen, Christian Leo-Hansen, et al.
Plos One|September 26, 2019
DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigsMarta Sisteré-Oró, Sergi López-Serrano, Veljko Veljkovic, et al.
Plos One|September 12, 2013
Selected HIV-1 Env trimeric formulations act as potent immunogens in a rabbit vaccination modelLeo Heyndrickx, Guillaume Stewart-Jones, Marianne Jansson, et al.
Veterinary Immunology and Immunopathology|December 19, 2017
Protective effect of a polyvalent influenza DNA vaccine in pigsIngrid Karlsson, Marie Borggren, Maiken Worsøe Rosenstierne, et al.
The Journal of Infectious Diseases|February 5, 2019
Cross-Reactive Antibodies With the Capacity to Mediate HIV-1 Envelope Glycoprotein-Targeted Antibody-Dependent Cellular Cytotoxicity Identified in HIV-2-Infected IndividualsIngrid Karlsson, Jeanette Linnea Tingstedt, Gülşen Özkaya Şahin, et al.
Journal of Translational Medicine|July 10, 2013
Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolateMaria Luisa Visciano, Maria Tagliamonte, Guillaume Stewart-Jones, et al.
The Lancet. Infectious Diseases|October 21, 2022
Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in DenmarkChristian Holm Hansen, Nikolaj Ulrik Friis, Peter Bager, et al.
Plos One|March 2, 2019
Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challengeMarta Sisteré-Oró, Júlia Vergara-Alert, Thomas Stratmann, et al.
Clinical and Vaccine Immunology : CVI|October 20, 2012
Clade A HIV-1 Gag-specific T cell responses are frequent but do not correlate with viral loads in a cohort of treatment-naive HIV-infected individuals living in Guinea-BissauKristoffer Jarlov Jensen, Victor Raúl Gómez Román, Sanne Skov Jensen, et al.
Plos One|July 28, 2022
Optimization and evaluation of a live virus SARS-CoV-2 neutralization assayAnders Frische, Patrick Terrence Brooks, Mikkel Gybel-Brask, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Clinical and Vaccine Immunology : CVI|June 8, 2012
Assessment of HIV-1 patient recruitability in the Republic of Guinea-Bissau using African versus North American hematology and biochemistry reference intervalsVictor Raúl Gómez Román, Sanne Skov Jensen, Christian Leo-Hansen, et al.
Plos One|September 26, 2019
DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigsMarta Sisteré-Oró, Sergi López-Serrano, Veljko Veljkovic, et al.
Plos One|September 12, 2013
Selected HIV-1 Env trimeric formulations act as potent immunogens in a rabbit vaccination modelLeo Heyndrickx, Guillaume Stewart-Jones, Marianne Jansson, et al.
Veterinary Immunology and Immunopathology|December 19, 2017
Protective effect of a polyvalent influenza DNA vaccine in pigsIngrid Karlsson, Marie Borggren, Maiken Worsøe Rosenstierne, et al.
The Journal of Infectious Diseases|February 5, 2019
Cross-Reactive Antibodies With the Capacity to Mediate HIV-1 Envelope Glycoprotein-Targeted Antibody-Dependent Cellular Cytotoxicity Identified in HIV-2-Infected IndividualsIngrid Karlsson, Jeanette Linnea Tingstedt, Gülşen Özkaya Şahin, et al.
Journal of Translational Medicine|July 10, 2013
Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolateMaria Luisa Visciano, Maria Tagliamonte, Guillaume Stewart-Jones, et al.
The Lancet. Infectious Diseases|October 21, 2022
Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in DenmarkChristian Holm Hansen, Nikolaj Ulrik Friis, Peter Bager, et al.
Plos One|March 2, 2019
Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challengeMarta Sisteré-Oró, Júlia Vergara-Alert, Thomas Stratmann, et al.
Clinical and Vaccine Immunology : CVI|October 20, 2012
Clade A HIV-1 Gag-specific T cell responses are frequent but do not correlate with viral loads in a cohort of treatment-naive HIV-infected individuals living in Guinea-BissauKristoffer Jarlov Jensen, Victor Raúl Gómez Román, Sanne Skov Jensen, et al.
Plos One|July 28, 2022
Optimization and evaluation of a live virus SARS-CoV-2 neutralization assayAnders Frische, Patrick Terrence Brooks, Mikkel Gybel-Brask, et al.
Pageof 12